Download Synergistic stabilization of BCS Class II drug

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts

Polysubstance dependence wikipedia , lookup

Orphan drug wikipedia , lookup

Compounding wikipedia , lookup

Pharmaceutical marketing wikipedia , lookup

Pharmacogenomics wikipedia , lookup

Nicholas A. Peppas wikipedia , lookup

Bad Pharma wikipedia , lookup

Pharmacognosy wikipedia , lookup

Neuropharmacology wikipedia , lookup

Drug interaction wikipedia , lookup

Drug design wikipedia , lookup

Medication wikipedia , lookup

Prescription costs wikipedia , lookup

Pharmaceutical industry wikipedia , lookup

Drug discovery wikipedia , lookup

Pharmacokinetics wikipedia , lookup

Transcript
Synergistic stabilization of BCS Class II drug nanosuspensions via
combination of cellulosic polymers and anionic surfactants
Meng Li, Afolawemi Afolabi, Anthony Quarato, Ecevit Bilgili
Department of Chemical, Biological and Pharmaceutical Engineering, New Jersey Institute of
Technology
Abstract:
Ensuring the physical stability of drug nanosuspensions prepared via wet media
milling has been a challenge for pharmaceutical scientists. The aim of this study is
to assess the combined use of non-ionic cellulosic polymers and anionic surfactants
in stabilizing multiple drug nanosuspensions. Particle size of five drugs, i.e.
azodicarbonamide (AZD), fenofibrate (FNB), griseofulvin (GF), ibuprofen (IBU)
and phenylbutazone (PB) was reduced separately in an aqueous solution of
hydroxypropyl cellulose (HPC) with/without sodium dodecyl sulfate (SDS) via a
stirred media mill. Laser diffraction, scanning electron microscopy, thermal analysis,
rheometry and electrophoresis were used to evaluate the breakage kinetics, storage
stability, electrostatic repulsion and stabilizer adsorption. Without SDS, drug
particles exhibited aggregation to different extents; FNB and GF particles
aggregated the most due to low zeta potential and insufficient steric stabilization.
Although aggregation in all milled suspensions was reduced due to HPC–SDS
combination, FNB and IBU showed notable growth during 7-day storage. It is
concluded that the combination of non-ionic cellulosic polymers and anionic
surfactants is generally viable for ensuring the physical stability of wet-milled drug
nanosuspensions, provided that the surfactant concentration is optimized to mitigate
the Ostwald ripening, whereas cellulosic polymers alone may provide stability for
some drug suspensions.